Tirzepatide Compared to Insulin Glargine for Type 2 Diabetes Control
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metformin With or Without Sulfonylurea (SURPASS-AP-Combo)
Study Design
Population
Patients with type 2 diabetes.
Comparator
Insulin glargine.
Outcome
Control of type 2 diabetes.
Abstract
A Randomized, Phase 3, Open-label Trial Comparing the Effect of Tirzepatide Once Weekly Versus Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes on Metformin With or Without a Sulfonylurea
NCT ID: NCT04093752
S…